Triphase Accelerator
Business Services · Canada · 11-50 Employees
View Company Info for Free
Overview
Headquarters
661 University Ave Ste 465, Toronto, Ont...Phone Number
(858) 295-4322Website
www.triphaseco.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Triphase Accelerator
Triphase Accelerator is a private drug development company with a primary focus on oncology and with operations in Toronto and San Diego. Triphase Accelerator is dedicated to advancing novel compounds through Phase 2 proof-of-concept clinical studies using a unique, science-based model that is faster and more cost-effective than traditional pharmaceutical and biotech industry drug development approaches. Triphase Accelerator was founded by the Ontario Institute for Cancer Research (OICR), in partnership with MaRS Innovation and MaRS. It has a strategic relationship with Celgene for oncology-focused drug development opportunities. In 2010, Celgene acquired the company's assets related to its proteasome inhibitor, marizomib (MRZ), which is currently in Phase 3 development for glioblastoma.Explore more
Triphase Accelerator Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Triphase Accelerator your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Triphase Accelerator
Check if Triphase Accelerator has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Triphase Accelerator is spiking on competitors!
Funding: Get notified immidiatlly once Triphase Accelerator has new funding data
Click to see if Triphase Accelerator had a recent Job posting/layoffs
Triphase Accelerator, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Triphase Accelerator recently announced quarterly report
Product Launch: Get notified when Triphase Accelerator launches new products
Website visits: Recent activity has been detected on your website
Recommended Actions
Reach out to Masked Content who joined Triphase Accelerator as Masked Content
Find more new buyers
Compare Similar Companies to Triphase Accelerator
Compare insights from companies similar to Triphase Accelerator, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Triphase Accelerator is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Triphase Accelerator is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Triphase Accelerator.
Triphase Accelerator Tech Stack
A closer look at the technologies used by Triphase Accelerator
See more technologies
Triphase Accelerator News & Media
Triphase Accelerator Announces Positive Interim Results of Phase 1 Trial of TRPH-222 in Patients with Relapsed/Refractory Non-Hodgkin Lymphoma
Oral Presentation to the American Society of Hematology (ASH) 2020 Annual Meeting Oral Presentation to the American Society of Hematology (ASH) 2020 Annual MeetingTriphase Accelerator and Catalent Announce Interim Results of a Dose...
Triphase Accelerator and Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer... (PRWeb May 18, 2020) Read the full story at https://www.prweb.com/releases/triphase_accelerator_and_catalent_announce_interim_results_of_a_dose_escalation_phase_1_clinical_trial_of_trph_222_in_patients_with_non_hodgkins_lymphoma/prweb17129205.htmTriphase Accelerator Initiates Phase 1 Clinical Trial of TRPH-222 in B-cell Lymphoma
Next Generation Antibody-Drug Conjugate Developed Using Catalent’s SMARTag® ADC Technology Next Generation Antibody-Drug Conjugate Developed Using Catalent’s SMARTag® ADC TechnologyTriphase Accelerator Initiates Phase 1 Clinical Trial of TRPH-222 in...
Triphase Accelerator Corporation, a company dedicated to acquiring and developing novel therapeutics for the treatment of cancer, and Catalent, the leading global provider of advanced delivery... (PRWeb April 01, 2019) Read the full story at https://www.prweb.com/releases/triphase_accelerator_initiates_phase_1_clinical_trial_of_trph_222_in_b_cell_lymphoma/prweb16209620.htm
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Triphase Accelerator
Sign Up For FreeTo access detailed company insights
Triphase Accelerator is a private drug development company with a primary focus on oncology and with operations in Toronto and San Diego. Triphase Accelerator is dedicated to advancing novel compounds through Phase 2 proof-of-concept clinical studies using a unique, science-based model that is faster and more cost-effective than traditional pharmac... Read More
